AngioDynamics Inc. priced a secondary offering of 2.35 million shares at $16.20 apiece.
The stocks will be sold by certain shareholders of the company and AngioDynamics will not receive any proceeds from the sale.
Barclays Capital Inc. is acting as the sole underwriter for the offering.